IBDEI1DI ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22893,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,22893,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,22894,0)
 ;;=I65.29^^104^1067^10
 ;;^UTILITY(U,$J,358.3,22894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22894,1,3,0)
 ;;=3^Carotid Artery Occlusion/Stenosis,Unspec
 ;;^UTILITY(U,$J,358.3,22894,1,4,0)
 ;;=4^I65.29
 ;;^UTILITY(U,$J,358.3,22894,2)
 ;;=^5007363
 ;;^UTILITY(U,$J,358.3,22895,0)
 ;;=I23.0^^104^1067^11
 ;;^UTILITY(U,$J,358.3,22895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22895,1,3,0)
 ;;=3^Certain Sequelae of MI
 ;;^UTILITY(U,$J,358.3,22895,1,4,0)
 ;;=4^I23.0
 ;;^UTILITY(U,$J,358.3,22895,2)
 ;;=^5007094
 ;;^UTILITY(U,$J,358.3,22896,0)
 ;;=I82.509^^104^1067^12
 ;;^UTILITY(U,$J,358.3,22896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22896,1,3,0)
 ;;=3^Chr DVT/Embolism Lower Extremity,Unspec
 ;;^UTILITY(U,$J,358.3,22896,1,4,0)
 ;;=4^I82.509
 ;;^UTILITY(U,$J,358.3,22896,2)
 ;;=^5133628
 ;;^UTILITY(U,$J,358.3,22897,0)
 ;;=K70.0^^104^1067^13
 ;;^UTILITY(U,$J,358.3,22897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22897,1,3,0)
 ;;=3^Chronic Liver Disease
 ;;^UTILITY(U,$J,358.3,22897,1,4,0)
 ;;=4^K70.0
 ;;^UTILITY(U,$J,358.3,22897,2)
 ;;=^5008784
 ;;^UTILITY(U,$J,358.3,22898,0)
 ;;=E56.1^^104^1067^29
 ;;^UTILITY(U,$J,358.3,22898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22898,1,3,0)
 ;;=3^Vitamin K Deficiency
 ;;^UTILITY(U,$J,358.3,22898,1,4,0)
 ;;=4^E56.1
 ;;^UTILITY(U,$J,358.3,22898,2)
 ;;=^5002801
 ;;^UTILITY(U,$J,358.3,22899,0)
 ;;=Z96.649^^104^1067^14
 ;;^UTILITY(U,$J,358.3,22899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22899,1,3,0)
 ;;=3^Hip Joint Replacement
 ;;^UTILITY(U,$J,358.3,22899,1,4,0)
 ;;=4^Z96.649
 ;;^UTILITY(U,$J,358.3,22899,2)
 ;;=^5063704
 ;;^UTILITY(U,$J,358.3,22900,0)
 ;;=Z96.659^^104^1067^15
 ;;^UTILITY(U,$J,358.3,22900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22900,1,3,0)
 ;;=3^Knee Joint Replacement
 ;;^UTILITY(U,$J,358.3,22900,1,4,0)
 ;;=4^Z96.659
 ;;^UTILITY(U,$J,358.3,22900,2)
 ;;=^5063708
 ;;^UTILITY(U,$J,358.3,22901,0)
 ;;=I69.90^^104^1067^17
 ;;^UTILITY(U,$J,358.3,22901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22901,1,3,0)
 ;;=3^Late Effects CVA
 ;;^UTILITY(U,$J,358.3,22901,1,4,0)
 ;;=4^I69.90
 ;;^UTILITY(U,$J,358.3,22901,2)
 ;;=^5007551
 ;;^UTILITY(U,$J,358.3,22902,0)
 ;;=I34.8^^104^1067^19
 ;;^UTILITY(U,$J,358.3,22902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22902,1,3,0)
 ;;=3^Mitral Valve Disorders NEC
 ;;^UTILITY(U,$J,358.3,22902,1,4,0)
 ;;=4^I34.8
 ;;^UTILITY(U,$J,358.3,22902,2)
 ;;=^5007172
 ;;^UTILITY(U,$J,358.3,22903,0)
 ;;=I23.0^^104^1067^20
 ;;^UTILITY(U,$J,358.3,22903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22903,1,3,0)
 ;;=3^Mural Thrombus
 ;;^UTILITY(U,$J,358.3,22903,1,4,0)
 ;;=4^I23.0
 ;;^UTILITY(U,$J,358.3,22903,2)
 ;;=^5007094
 ;;^UTILITY(U,$J,358.3,22904,0)
 ;;=I73.9^^104^1067^22
 ;;^UTILITY(U,$J,358.3,22904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22904,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,22904,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,22904,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,22905,0)
 ;;=Z86.79^^104^1067^23
 ;;^UTILITY(U,$J,358.3,22905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22905,1,3,0)
 ;;=3^Personal Hx of Circulatory System Disease NEC
 ;;^UTILITY(U,$J,358.3,22905,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,22905,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,22906,0)
 ;;=Z86.72^^104^1067^24
 ;;^UTILITY(U,$J,358.3,22906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22906,1,3,0)
 ;;=3^Personal Hx of Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,22906,1,4,0)
 ;;=4^Z86.72
